Healthcare provider profile · identity verified

Antonio Pena, MD

Internal Medicine · PORTLAND, OR · NPI 1760531115

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	649	200
Losartan Potassium	Losartan Potassium	441	136
Levothyroxine Sodium	Levothyroxine Sodium	358	96
Amlodipine Besylate	Amlodipine Besylate	317	103
Metoprolol Succinate	Metoprolol Succinate	280	77
Famotidine	Famotidine	254	76
Pravastatin Sodium	Pravastatin Sodium	237	70
Rosuvastatin Calcium	Rosuvastatin Calcium	221	71
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	195	32
Gabapentin	Gabapentin	181	61
Omeprazole	Omeprazole	177	64
Tamsulosin Hcl	Tamsulosin Hcl	172	58
Lisinopril	Lisinopril	160	52
Eliquis	Apixaban	152	38
Bupropion Xl	Bupropion Hcl	148	37
Metformin Hcl	Metformin Hcl	141	46
Albuterol Sulfate Hfa	Albuterol Sulfate	138	57
Trazodone Hcl	Trazodone Hcl	129	41
Tizanidine Hcl	Tizanidine Hcl	115	45
Potassium Chloride	Potassium Chloride	111	34
Simvastatin	Simvastatin	104	30
Allopurinol	Allopurinol	97	30
Furosemide	Furosemide	96	37
Donepezil Hcl	Donepezil Hcl	90	22
Montelukast Sodium	Montelukast Sodium	85	24
Finasteride	Finasteride	83	30
Quetiapine Fumarate	Quetiapine Fumarate	83	18
Sertraline Hcl	Sertraline Hcl	83	20
Memantine Hcl	Memantine Hcl	82	16
Zolpidem Tartrate	Zolpidem Tartrate	76	29
Prednisone	Prednisone	70	33
Oxycodone Hcl	Oxycodone Hcl	69	17
Hydralazine Hcl	Hydralazine Hcl	68	18
Escitalopram Oxalate	Escitalopram Oxalate	65	22
Metoprolol Tartrate	Metoprolol Tartrate	64	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	63	18
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	63	20
Azithromycin	Azithromycin	61	34
Duloxetine Hcl	Duloxetine Hcl	60	18
Ipratropium Bromide	Ipratropium Bromide	60	23
Citalopram Hbr	Citalopram Hydrobromide	59	16
Hydrochlorothiazide	Hydrochlorothiazide	58	20
Metformin Hcl Er	Metformin Hcl	57	18
Pantoprazole Sodium	Pantoprazole Sodium	56	18
Ozempic	Semaglutide	54	12
Atenolol	Atenolol	52	17
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	51	29
Glimepiride	Glimepiride	51	18
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	51	34
Hydroxyzine Hcl	Hydroxyzine Hcl	50	suppressed
Alprazolam	Alprazolam	46	14
Clopidogrel	Clopidogrel Bisulfate	46	11
Alendronate Sodium	Alendronate Sodium	45	15
Carvedilol	Carvedilol	44	16
Fluticasone Propionate	Fluticasone Propionate	43	28
Meloxicam	Meloxicam	43	16
Doxycycline Hyclate	Doxycycline Hyclate	42	31
Fluoxetine Hcl	Fluoxetine Hcl	42	15
Primidone	Primidone	42	suppressed
Synthroid	Levothyroxine Sodium	41	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	38	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	36	suppressed
Spironolactone	Spironolactone	36	11
Valacyclovir	Valacyclovir Hcl	36	14
Jardiance	Empagliflozin	35	suppressed
Telmisartan	Telmisartan	34	11
Paroxetine Hcl	Paroxetine Hcl	32	suppressed
Eszopiclone	Eszopiclone	31	11
Lorazepam	Lorazepam	31	21
Warfarin Sodium	Warfarin Sodium	30	11
Clonidine Hcl	Clonidine Hcl	29	12
Levetiracetam	Levetiracetam	29	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	27	20
Celecoxib	Celecoxib	26	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	26	suppressed
Ezetimibe	Ezetimibe	26	11
Paxlovid	Nirmatrelvir/Ritonavir	26	26
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	25	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	25	suppressed
Acyclovir	Acyclovir	24	11
Amiloride-Hydrochlorothiazide	Amiloride/Hydrochlorothiazide	24	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	24	11
Ondansetron Odt	Ondansetron	24	suppressed
Xarelto	Rivaroxaban	23	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	13
Diltiazem 24hr Er	Diltiazem Hcl	22	suppressed
Estradiol	Estradiol	22	suppressed
Farxiga	Dapagliflozin Propanediol	22	suppressed
Glipizide Er	Glipizide	22	suppressed
Ondansetron Hcl	Ondansetron Hcl	22	suppressed
Tramadol Hcl	Tramadol Hcl	22	suppressed
Nitroglycerin	Nitroglycerin	21	13
Cephalexin	Cephalexin	20	12
Hydrocortisone	Hydrocortisone	20	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	20	suppressed
Diclofenac Sodium	Diclofenac Sodium	18	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	18	suppressed
Pregabalin	Pregabalin	18	suppressed
Benazepril Hcl	Benazepril Hcl	17	suppressed
Diazepam	Diazepam	17	suppressed
Entresto	Sacubitril/Valsartan	17	suppressed
Myrbetriq	Mirabegron	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	16	suppressed
Fluocinonide	Fluocinonide	16	13
Baclofen	Baclofen	15	suppressed
Colesevelam Hcl	Colesevelam Hcl	15	suppressed
Liothyronine Sodium	Liothyronine Sodium	15	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	15	suppressed
Torsemide	Torsemide	15	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Testosterone	Testosterone	14	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	13	suppressed
Glipizide	Glipizide	13	suppressed
Metronidazole	Metronidazole	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Loperamide	Loperamide Hcl	12	suppressed
Nystatin	Nystatin	12	suppressed
Ramipril	Ramipril	12	suppressed
Epinephrine	Epinephrine	11	suppressed
Mirtazapine	Mirtazapine	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed
Trulicity	Dulaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error